透明质酸的制备与鉴定

透明质酸是一种酸性粘多糖,其特有的粘弹性和保湿性已被用于医药与化妆品的生产中。本文以黄牛眼睛为材料,通过提取,除杂质、有机溶剂沉淀等步骤进行透明质酸的制备,并对其性质进行鉴定,表明用此方法制备的透明质酸基本达到了市场的要求,而且此工艺简单,成本低廉。     

抗α-INF卵黄抗体的制备与鉴定

用人抑制素（１－２６）Ｔｙｒ．Ｇｌｙ与ＫＬＨ连接作免疫原,免疫本地良种母鸡,观察血清及卵黄中特异性抗体的应答,结果经免疫的鸡免疫应答,所产卵的卵黄中可检出大量的有高度活性的抗体。综合运用ｐＨ值、非示蛋白沉淀法和球蛋白沉淀法,制得纯度较高的抗抑制素ｅＩｇＹ。采用阻断ＥＬＩＳＡ法证实所获得的ｅＩｇＹ具有高度的特异性。用ｅＩｇＹ被动免疫未成年昆明鼠,子宫重量明显增加,由此可以用鸡做生物反应器大量生产抗抑     

铅螯合物人工抗原的制备与鉴定

以双功能螯合剂异硫氰酸苄基乙二胺四乙酸(ITCBE)螯合铅离子,制备得半抗原Pb-ITCBE,然后再分别与载体蛋白KLH或BSA偶联制备得免疫原Pb-ITCBE-KLH与包被抗原Pb-ITCBE-BSA,ITCBE-BSA.用二喹啉甲酸法测3种抗原的浓度,分析半抗原、抗原与载体蛋白的紫外吸收光谱,利用SDS-PAGE对3种抗原的分子量进行鉴定,用三硝基苯磺酸法检测3种抗原中的赖氨酸残基的ε-NH2被半抗原替换的程度,用石墨炉原子分光吸收法检测抗原中铅的含量.研究结果表明,免疫原与包被抗原制备成功,Pb-ITCBE-KLH、Pb-ITCBE-BSA、ITCBE-BSA的浓度依次为6.47± 0.08 mg/ml,6.68± 0.06 mg/ml,5.57± 0.05 mg/ml;抗原与载体蛋白的紫外吸收光谱的特征各不相同;SDS-PAGE的结果显示3种抗原的分子量均不同于各自的载体蛋白;抗原中载体蛋白ε-氨基的替换程度依次为1.86± 0.74 %、55.53± 1.13%、54.19± 1.34%;铅的含量依次为15.64± 0.11 μg/ml,17.33± 0.15 μg/ml,0 μg/ml.     

肺炎支原体抗独特型卵黄抗体的制备与鉴定

目的制备肺炎支原体(M.pneumonia)抗独特型卵黄抗体(vitelline Ab2),鉴定其生物学特性,探讨其作为动物疫苗的潜在应用价值。方法首先制备兔、小鼠抗肺炎支原体抗体(Ab1),筛选出对肺炎支原体有免疫中和性的兔抗体和小鼠抗体,再用兔抗体免疫产蛋鸡,筛选并收集有高效价抗独特型卵黄抗体的鸡蛋,分离蛋黄,破碎蛋黄组织,用蒸馏水稀释和酸化提取抗独特型卵黄抗体。用冷酒精沉淀法纯化抗独特型卵黄抗体。用ELISA检测肺炎支原体抗独特型卵黄抗体(Ab2)的效价、质量浓度和特异性。用竞争抑制试验和动物免疫检测卵黄Ab2β。结果兔抗肺炎支原体抗体的效价为1×10~(-6),Ab1的效价为1×10~(-4)～1×10~(-5);以上抗体均只和肺炎支原体发生免疫反应,不和解脲支原体发生免疫反应;它们和肺炎支原体混合后能中和肺炎支原体的活性,使其不能在条件培养基生长。Ab2效价为1×10~(-5),质量浓度为8 mg/mL。该抗独特型卵黄抗体只和Ab1发生免疫反应,不和小鼠抗解脲支原体抗体发生免疫反应。该Ab2和Ab1结合能被肺炎支原体竞争抑制,且Ab2能诱导小鼠产生肺炎支原体抗体(Ab3),该Ab3能和肺炎支原体发生免疫反应。结论成功制备了特异性强、效价高的β型Ab2,具有作为动物肺炎支原体疫苗的潜在应用价值。     

Tropic1808基因重组蛋白单克隆抗体的制备及鉴定

目的：制备Tropic1808基因重组蛋白的单克隆抗体,并对其生物学特性进行鉴定。方法：用Tropic1808基因重组蛋白作为抗原免疫BALB/C小鼠,取小鼠脾细胞与小鼠骨髓瘤（SP2/0）细胞融合,经ELISA筛选和有限稀释法获得分泌单克隆抗体的细胞株,Western Blot等方法对其生物学特性进行鉴定。结果：获得2株识别Tropic1808基因重组蛋白的单克隆抗体的细胞株Ⅱ4B、Ⅲ4C。WesternBlot法显示该抗体特异性地识别Tropic1808基因重组蛋白;ELISA法测定杂交瘤细胞培养上清及体内成瘤后产生的腹水的抗体效价分别为1：80、1：600;杂交瘤细胞染色体数平均为90-100;亚类鉴定单抗的重链为小鼠IgG1,轻链为κ型。结论：成功地制备了Tropic1808基因重组蛋白的单克隆抗体,为进一步研究Tropic1808基因重组蛋白的功能提供了良好的基础。     

兔肝金属硫蛋白β结构域的制备和鉴定

制备一定量的Ｃｄ、Ｚｎ兔肝金属硫蛋白,然后脱掉其中的金属,获得不含金属的硫蛋白,用一价金属ＣｕＣｌ或ＡｇＮＯ３以５．８：１的金属：蛋白摩尔比与ａｐｏＭＴ结合,将其β结构域用金属饱和,在３７℃,ＰＨ７．０下用枯草杆菌蛋白酶水解掉未结合金属的α结构域,获得Ｃｕ（Ⅰ）、Ａｇ（Ⅰ）结合的兔肝ＭＴ－Ⅰ、ＭＴ－Ⅱ的β结构域,通过ＨＰＬＣ、羧甲基化后的ＳＤＳ－ＰＡＧＥ、氨基酸组成分析、金属定量、Ｎ末端分析和紫外     

Preparation and hydrolytic degradation of semi-interpenetrating networks of poly(3-hydroxyundecenoate) and poly(lactide-co-glycolide)

Semi-interpenetrating networks (semi-IPNs), where poly(lactide-co-glycolide) (PLGA) molecules were entrapped in the crosslinked matrices of poly(3-hydroxyundecenoate) (PHU), were prepared by irradiating homogeneous solutions of PHU and PLGA in chloroform with UV light. Attenuated total reflectance infrared spectroscopy showed that the PLGA chains were entrapped in PHU networks. The semi-IPNs showed enhanced mechanical strength as the PLGA content increased. The semi-IPNs were incubated at 37 °C in a 0.01N NaOH solution, and the extent of hydrolytic degradation was investigated by monitoring changes in various parameters such as water uptake, pH, mass, and morphology. Hydrolysis of semi-IPNs were significantly affected by the presence of PLGA. A semi-IPN prepared from a 9:1 (by weight) mixture of PHU and PLGA lost 25% of its original weight in 12 weeks while a PHU sample containing no PLGA lost only 5% of its weight during the same period under identical conditions. The hydrolysis was most likely accelerated when the pH of the medium was lowered by the hydrolyzed products of PLGA, 2-hydroxyalkanoic acids. These results showed that hydrolysis of PHA could be enhanced by incorporating a second component that lowered the pH of the hydrolysis system.     

125I和65Zn在大蟾蜍体内的吸收与分布

利用同位素示踪法研究了不同引入途径的125I和65Zn在大蟾蜍体内的吸收与分布。无论采用注射还是灌喂的方法,蟾蜍对125I的残留动态差别不大,都可分为快清除期和平台期,0～2d为快清除期,3～7d为平台期,经过了快清除期之后,残留的125I约为起始量的8%,并维持到实验结束。注射了65Zn后,0～7d的吸收动态曲线有所起伏,但波动很小,其波动范围为102.4%～114.48%。表明大部分的65Zn仍留在体内,几乎没有排出体外。注射65Zn的转移并不明显。但灌喂65Zn的动态变化则大些,而且转移明显。其活度曲线出现阶段性下降,有两个下降期,第一个下降期为4h～3d,第二个下降期为5～7d。说明灌喂组对65Zn的转移比注射组的活跃,但在实验的第7d残留率仍在60%以上。     

125I粒子植入治疗中晚期食管鳞癌围手术期护理

目的:探讨125I粒子植入治疗中晚期食管鳞癌围手术期的护理的临床效应。方法:2000.01-2005.12间IIb-III期233例胸段食管鳞癌患者随机分为根治加125I粒子植入组(n=112)和单纯性根治术组(n=121)。术前进行放疗知识的专业宣教,根据CT影像资料,根据术前TPS计划模拟肿块所布源的最外层粒子总数作为最终植入数,一般为10～22粒,约为计算量的2/5,术中直视下125I粒子(北京原子高科公司提供)组织间植入。术后防护宣教;用γ射线探测仪检查患者周围的射线强度;通过X摄片观察粒子位移和质量评估;观察术后并发症及生存率。结果:所有患者术后粒子验证无移位、脱落,技术评估满意;未见出血量增加和吻合口瘘。结论:术中125I粒子植入治疗中晚期食管鳞癌,患者依从性好;放射污染小;操作简单、安全;有效降低局部复发率而不增加手术并发症。     

Synthesis and structural characterization of two new polynuclear metal thiosaccharinates: Hexakis(thiosaccharinato)hexasilver(I) and tetrakis(thiosaccharinato)tetracopper(I)

The title compounds, for short Ag₆(tsac)₆ (1) and [Cu₄(tsac)₄(MeCN)₂] · 2MeCN (2), were prepared by the reaction of thiosaccharin with Ag(I) or Cu(II) salts in different solvents. The new complexes were characterized by FT-IR, Raman, UV-Vis and NMR spectroscopy. Their crystal and molecular structures were determined by X-ray diffraction methods. The structures were solved from 1621 (1) and 7080 (2) reflections with I > 2σ(I) and refined to agreement R1-factors of 0.0261 (1) and 0.0456 (2). Ag₆(tsac)₆ molecule derives from the clustering of six Ag(tsac) moieties related to each other through the crystallographic 3-bar (S₆) symmetry operations of the space group. This results in a highly regular molecular structure where the silver atoms are at the corners of an octahedral core slightly compressed along one of its three-fold axis [inter-metallic Ag?Ag contacts of 3.1723(4) and 3.1556(4) Å]. The six thiosaccharinate ligands bridge neighboring Ag atoms along the C₃-axis through Ag-N bonds [d(Ag-N) = 2.285(2) Å] at one end and bifurcated Ag-S(thione)-Ag bonds [Ag-S distances of 2.4861(7) and 2.5014(8) Å] at the other end. In contrast, the 2 compound is arranged in the lattice as an irregular tetrameric copper complex [Cu₄(tsac)₄(MeCN)₂] where the metals show different environments. Two copper ions are four-fold coordinated to three tsac ions through the N-atom of one tsac [Cu-N distances of 2.112(3) and 2.064(3) Å] and the thione sulfur atom of the other two [Cu-S distances in the range from 2.284(1) to 2.358(1) Å] and to a MeCN solvent molecule [Cu-N distances of 1.983(4) and 2.052(3) Å]. The other two copper ions are in three-fold environment, one trans-coordinated to two tsac ions [Cu-N distances of 1.912(3) and 1.920(3) Å] and to the thione S-atom of a third ligand [d(Cu-S) = 2.531(1) Å], the other one to the thione sulfur atom of three tsac ligands [Cu-S distances in the range from 2.229(1) to 2.334(1) Å]. The clustering renders the metals to short distances from each other, the shorter Cu?Cu distance being 2.6033(7) Å, as to presume the existence of weak inter-metallic interaction within the cluster.     

Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro

Toll-like receptor 3 (TLR3) binds and signals in response to dsRNA and poly(I:C), a synthetic double stranded RNA analog. Activation of TLR3 triggers innate responses that may play a protective or detrimental role in viral infections or in immune-mediated inflammatory diseases through amplification of inflammation. Two monoclonal antibodies, CNTO4685 (rat anti-mouse TLR3) and CNTO5429 (CDRs from CNTO4685 grafted onto a mouse IgG1 scaffold) were generated and characterized. These mAbs bind the extracellular domain of mouse TLR3, inhibit poly(I:C)-induced activation of HEK293T cells transfected with mTLR3, and reduce poly(I:C)-induced production of CCL2 and CXCL10 by primary mouse embryonic fibroblasts. CNTO5429 decreased serum IL-6 and TNFα levels post-intraperitoneal poly(I:C) administration, demonstrating in vivo activity. In summary, specific anti-mTLR3 mAbs have been generated to assess TLR3 antagonism in mouse models of inflammation.     

Copper(I) and silver(I) tertiary phosphines complexes: Synthesis, X-ray structures and spectroscopic characterization

Six new complexes, [Cu₄I₄(PPh₂Cy)₄]·2H₂O (1), [CuI(PPhCy₂)₂] (2), [CuCl(PPhCy₂)₂] (3), and [CuBr(PPh₃)₃]·CH₃CN (4), [Ag(PPhCy₂)₂(NO₃)] (5), [Ag(PCy₃)(NO₃)]₂ (6) [where Ph = phenyl, Cy = cyclohexyl], have been synthesized and structurally characterized by X-ray diffraction, IR absorption spectra and NMR spectroscopic studies (except complex 4). The X-ray diffraction analysis of complex (1), pseudo polymorph of complex [Cu₄I₄(PPh₂Cy)₄], reveals a stella quadrangula structure. The four corners of the cube are occupied by copper(I) atoms and four I atoms are present at the alternative corners of the cube, further more the copper(I) atoms are coordinated to a monodentate tertiary phosphine. Complexes (2) and (3) are isostructural with trigonal planar geometry around the copper(I) atom. The crystal structure of complex (4) is a pseudo polymorph of complex [CuBr(PPh₃)₃] and the geometrical environment around the copper(I) centre is distorted tetrahedral. In the Ag^I complexes (5) and (6), the central metal atoms have pseudo tetrahedral and trigonal planar geometry, respectively. Spectroscopic and microanalysis results are consistent with the single crystal X-ray diffraction studies.     

载阿霉素PLGA纳米微球的制备及性质研究

目的:制备新型癌症化疗制剂载阿霉素(Adriamycin)、聚乳酸-羟基乙酸共聚物(PLGA)纳米微球(ADM-PLGA-NP),研究其性质及体外释药特点。方法:以聚乳酸-羟基乙酸共聚物为包封材料,阿霉素为模型药物,采用复乳蒸发法制备ADM-PLGA-NP,扫描电镜观察微球形态,激光粒度分析仪检测粒径分布,紫外分光光度法计算载药率及包封率,体外药物释放实验考察微球对ADM的缓释作用。结果:ADM-PLGA-NP外观呈球形,平均粒径约(237±12.7)nm,载药量及包封率分别为(6.42±1.67)%和(53.82±8.34)%,药物在体外缓慢释放,5 d累积释放量达85%。结论:通过复乳蒸发法制备的ADM-PLGA-NP性质稳定,具有药物缓释性,有望成为一种新型的药物化疗载体。     

Synthesis of Stable Isotope Labeled Analogs of the Anti-Hepatitis C Virus Nucleotide Prodrugs PSI-7977 and PSI-352938

In order to support bioanalytical LC/MS method development and plasma sample analysis in preclinical and clinical studies of the anti-hepatitis C-virus nucleotides, PSI-7977 and PSI-352938, the corresponding stable isotope labeled forms were prepared. These labeled compounds were prepared by addition reaction of the freshly prepared Grignard reagent ¹³CD₃MgI to the corresponding 2 ′-ketone nucleosides followed by fluorination of the resulting carbinol with DAST. As expected, these 2 ′-C-(trideuterated-¹³C-methyl) nucleotide prodrugs showed similar anti-HCV activity to that of the corresponding unlabeled ones.     

Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity

The purpose of this study was to investigate the formation of acylated impurity resulting from a chemical reaction between the growth hormone-releasing peptide-6 (GHRP-6) and poly(lactide-co-glycolide) (PLGA) and the effect of peptide acylation on the in vivo biological activity of GHRP-6. The peptide acylation pattern of GHRP-6 by hydrophilic PLGA polymers with different molecular weights was characterized by reversed-phase high-performance liquid chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Higher levels of acylated GHRP-6 were produced with the higher molecular weight PLGA, which might be due to the slower degradation rate of the polymer. The evaluation of the biological activity in rats showed that the acylated GHRP-6 had a much lower activity than the intact GHRP-6. This finding suggests that the acylation reaction would decrease the effectiveness of the GHRP-6 formulation such as PLGA microspheres. There-fore, a strategy for stabilizing the GHRP-6 will be necessary for the development of a successful formulation of PLGA microspheres. Published: June 8, 2007